Details for 2018716455
Up to date per 04.04.2026
Actions
Details for 2018716455
Granted/Registered
European Patent
06.03.2019 A
10.07.2019 B1
20.03.2017
US
201762473751 P
C07D 487/04 20060101AFI20180928BHEP
Owner
Novo Nordisk Health Care AGThe Circle 32/388058 ZürichCH
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
ERICSSON, Annac/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
GREEN, Nealc/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
GUSTAFSON, Garyc/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
HAN, Bingsongc/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
LANCIA, JR., David R.c/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
MITCHELL, Lornac/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
RICHARD, Davidc/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
SHELEKHIN, Tatianac/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
SMITH, Chase C.c/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
WANG, Zhongguoc/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
ZHENG, Xiaozhangc/o Forma Therapeutics Inc. 500 Arsenal Street Suite 100 Watertown, Massachusetts 02472US
Information about Fees